Inventor
HABER DANIEL A
US26 patents
⚠️ This page may combine multiple inventors who share the name “HABER DANIEL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MASSACHUSETTS GEN HOSPITAL
14 patentsUS11898209B2Feb 13, 2024
Digital analysis of circulating tumor cells in blood samples
MASSACHUSETTS GEN HOSPITAL2 citations68
US12006555B2Jun 11, 2024
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
MASSACHUSETTS GEN HOSPITAL0 citations62
US10900083B2Jan 26, 2021
Methods and assays relating to circulating tumor cells
MASSACHUSETTS GEN HOSPITAL1 citations60
US11142800B2Oct 12, 2021
Biomarkers of cancer
MASSACHUSETTS GEN HOSPITAL0 citations59
US9417244B2Aug 16, 2016
Cadherins as cancer biomarkers
MASSACHUSETTS GEN HOSPITAL2 citations59
US12152241B2Nov 26, 2024
Targeting human satellite II (HSATII)
MASSACHUSETTS GEN HOSPITAL1 citations58
US10301624B2May 28, 2019
Targeting human satellite II (HSATII)
MASSACHUSETTS GEN HOSPITAL1 citations58
US12522657B2Jan 13, 2026
Therapeutic targeting of Cadherin 11 in cancer
MASSACHUSETTS GEN HOSPITAL0 citations57
US11079383B2Aug 3, 2021
Diagnosis and monitoring treatment of prostate cancer
MASSACHUSETTS GEN HOSPITAL0 citations56
US10669589B2Jun 2, 2020
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
MASSACHUSETTS GEN HOSPITAL0 citations51
US10000815B2Jun 19, 2018
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
MASSACHUSETTS GEN HOSPITAL0 citations51
US10094837B2Oct 9, 2018
Cadherins as cancer biomarkers
MASSACHUSETTS GEN HOSPITAL0 citations48
US9766244B2Sep 19, 2017
Diagnosis and monitoring treatment of prostate cancer
MASSACHUSETTS GEN HOSPITAL0 citations46
US10876151B2Dec 29, 2020
LNA-based mutant enrichment next-generation sequencing assays
MASSACHUSETTS GEN HOSPITAL0 citations32
MASSACHUSETTS INST TECHNOLOGY
4 patentsUS5350840ASep 27, 1994
Localization and characterization of the Wilms' tumor gene
MASSACHUSETTS INST TECHNOLOGY143 citations96
US5726288AMar 10, 1998
Localization and characterization of the Wilms' tumor gene
MASSACHUSETTS INST TECHNOLOGY57 citations93
US6316599B1Nov 13, 2001
Localization and characterization of the Wilms' tumor gene
MASSACHUSETTS INST TECHNOLOGY29 citations89
US6943011B2Sep 13, 2005
Localization and characterization of the Wilms' tumor gene
MASSACHUSETTS INST TECHNOLOGY0 citations47
GEN HOSPITAL CORP
3 patentsUS7964349B2Jun 21, 2011
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
GEN HOSPITAL CORP92 citations98
US7294468B2Nov 13, 2007
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
GEN HOSPITAL CORP187 citations98
US9035036B2May 19, 2015
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
GEN HOSPITAL CORP8 citations83
BELL DAPHNE WINIFRED
2 patentsUS8465916B2Jun 18, 2013
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
BELL DAPHNE WINIFRED85 citations97
US8105769B2Jan 31, 2012
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
BELL DAPHNE WINIFRED97 citations96